These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4220002)

  • 21. Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.
    Daha MR; Fearon DT; Austen KF
    Immunology; 1976 Nov; 31(5):789-96. PubMed ID: 992711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 23. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
    West CD; Ruley EJ; Spitzer RE; Davis NC
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():531-40. PubMed ID: 4620926
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistent hypocomplementemia in membrano-proliferative glomerulonephritis.
    J Assoc Physicians India; 1978 Dec; 26(12):1167-70. PubMed ID: 752007
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation in glomerulonephritis.
    Baer D
    N Engl J Med; 1977 Jun; 296(22):1299. PubMed ID: 859526
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Membranoproliferative nephritis and C3NeF.
    N Engl J Med; 1976 Jun; 294(23):1293-5. PubMed ID: 1264160
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.
    Vallota EH; Forristal J; Spitzer RE; Davis NC; West CD
    J Exp Med; 1970 Jun; 131(6):1306-24. PubMed ID: 4192571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological varieties of membranoproliferative glomerulonephritis].
    Imbasciati E; Tarantino A; Ponticelli C; Giani M; Bardare M; Gaboardi F
    Minerva Nefrol; 1981; 28(3):415-9. PubMed ID: 7329619
    [No Abstract]   [Full Text] [Related]  

  • 30. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
    Vallota EH; Götze O; Spiegelberg HL; Forristal J; West CD; Müller-Eberhard HJ
    J Exp Med; 1974 May; 139(5):1249-61. PubMed ID: 4207623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavior of C3 and serum immunoglobulins in low-complement post-streptococcal acute glomerulonephritis in childhood].
    Masi M; Tazzari R
    Minerva Pediatr; 1977 Apr; 29(12):825-6. PubMed ID: 875956
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical evaluation and characterization of a unique C3 breakdown factor detected in a patient with acute glomerulonephritis.
    Fujita T; Ohi H; Seki M; Miyaji H; Hatano M
    Nephron; 1987; 47(1):56-61. PubMed ID: 3627335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function.
    Daha MR; Austen KF; Fearon DT
    J Immunol; 1977 Sep; 119(3):812-7. PubMed ID: 894027
    [No Abstract]   [Full Text] [Related]  

  • 34. Morphology and serum complement levels in membranoproliferative glomerulonephritis.
    Habib R; Loirat C; Gubler M; Levy M
    Adv Nephrol Necker Hosp; 1974; 4():109-36. PubMed ID: 4219989
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of complement in glomerulonephritis.
    Simpson IJ
    Aust N Z J Med; 1981; 11(Suppl 1):101-3. PubMed ID: 6942797
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transitory deficiency of Clq and C4 in a case of chronic glomerulonephritis].
    Schena FP; Piscitelli M; Lucivero G; Marzullo F
    Minerva Nefrol; 1975; 22(6):266-71. PubMed ID: 1223704
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complement system in glomerulonephritis. II. Detailed aspects].
    Bodalski J; Narebska E; Jerzmanowski A
    Pediatr Pol; 1980 Jun; 55(6):805-11. PubMed ID: 7413331
    [No Abstract]   [Full Text] [Related]  

  • 39. Alterations of complement components in disease.
    Luskin AT; Tobin MC
    Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
    Ruley EJ; Forristal J; Davis NC; Andres C; West CD
    J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.